On a global scale, there was a stark difference in access to COVID-19 vaccines between the Global North and Global South. With most vaccines initially developed and produced by only a handful of countries, the rest of the world had to rely on existing diplomatic ties, purchasing power, and donations to access these vaccines. Meanwhile, observable inequities between populations at the subnational level, exacerbated by socioeconomic, geographic, and citizenship status, resulted in further uneven access to COVID-19 vaccines. Different countries have implemented different strategies for the distribution of COVID-19 vaccines. Some have kept vulnerable and marginalised populations in mind, whereas others have implemented generalised vaccine distribution and inoculation strategies without considering vulnerable and marginalised populations. This has caused some countries to be far ahead of others in terms of vaccination rate and equity